FDA Safety Monitoring Could Rely On Data Links, Menactra Model – McClellan
Executive Summary
Former FDA Commissioner Mark McClellan was one of the main drivers behind the language in the FDA Amendments Act mandating an active surveillance system, and he continues to be involved in shaping the program how will be implemented
You may also be interested in...
FDA’s Sentinel Framework Should Preclude “Unbridled” Data Mining – Platt
FDA's nascent electronic post-market drug safety monitoring project - Sentinel - should be designed to investigate only known problems or specific issues raised by spontaneous reports or studies, Harvard University's Richard Platt recommends
FDA’s Sentinel Framework Should Preclude “Unbridled” Data Mining – Platt
FDA's nascent electronic post-market drug safety monitoring project - Sentinel - should be designed to investigate only known problems or specific issues raised by spontaneous reports or studies, Harvard University's Richard Platt recommends
FDA’s Sentinel Program Readies For Patrol As Stakeholders Watch For Details
HHS unveiled the first phase of FDA's "Sentinel" post-market drug safety surveillance initiative with fanfare May 22, but stakeholders will have to wait a while for details on funding and the timing of a full-scale rollout